BDBM640399 Synthesis of (3S)-3-{[3-cyclopropyl-N-(5,7-difluoro-1H-indole-2-carbonyl)-L-alanyl]amino}-2-oxo-4-[(3S)-2-oxopiperidin-3-yl]butyl L-valinate hydrochloride Salt, 17::US20230399296, Compound 17

SMILES CC(C)[C@H](N)C(=O)OCC(=O)[C@H](C[C@@H]1CCCNC1=O)NC(=O)[C@H](CC1CC1)NC(=O)c1cc2cc(F)cc(F)c2[nH]1

InChI Key InChIKey=PFFMSDXNZVSFTL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 640399   

TargetReplicase polyprotein 1ab(2019-nCoV)
University of Alberta

US Patent
LigandPNGBDBM640399(Synthesis of (3S)-3-{[3-cyclopropyl-N-(5,7-difluor...)
Affinity DataIC50: 50nMAssay Description:A synthesized fluorescent substrate containing the cleavage site (indicated by the arrow, ↓) of SARS-CoV-2 3CLP (2-Abz-SVTLQ↓SG-Tyr(NO2) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/3/2024
Entry Details
Go to US Patent